WELCOME
About Pharmazac
Pharmazac is a vastly growing company, dedicated in the development, manufacturing and commercialisation of pharmaceutical products in Greece and in more than 60 countries around the world.
CAPACITY
Today we count
40 years of history
250 products launched
3 operational sites
12+ certifications and awards
DISCOVER
What we do
Pharmaceuticals
For more than 40 years, we have been developing and manufacturing high-quality pharmaceutical formulations to serve patients and national healthcare systems
Diagnostics & Radiopharmaceutical
We are a regional champion in manufacturing and commercialising the latest solutions in CT, MRI and PET-Scan diagnosis, offering a complete range of diagnostic pharmaceuticals
Future Research Pipeline
We invest in the future with our Research and Development operations across multiple therapeutic categories
PIPELINE
Recent product launches
NANOCOLLOIDAL HUMAN ALBUMIN/RADIOPHARMACY LABORATORY RAD.PHA.KT 0.5mg/VIAL BTx6 VIALS
| NANOCOLLOIDAL HUMAN ALBUMIN/RADIOPHARMACY LABORATORY RAD.PHA.KT 0.5mg/VIAL BTx6 VIALS |
FLUDEOXYGLUCOSE (18F)/GE HEALTHCARE INJ.SOL 250MBq/mL BTx1 VIAL x (0.1-10mL)
| FLUDEOXYGLUCOSE (18F)/GE HEALTHCARE INJ.SOL 250MBq/mL BTx1 VIAL x (0.1-10mL) |
SODIUM IODIDE (I-123) INJ.SO.INF 37 MBq/ML BTx1 VIALx1 ML (1 mCi -10mCi/VIAL)
| SODIUM IODIDE (I-123) INJ.SO.INF 37 MBq/ML BTx1 VIALx1 ML (1 mCi -10mCi/VIAL) |
ADREVIEW INJ.SOL 74MBq/mL BTx1VIALx0,5mL (1mCi – 10mCi/vial)
| ADREVIEW INJ.SOL 74MBq/mL BTx1VIALx0,5mL (1mCi - 10mCi/vial) |
DATSCAN INJ.SOL 74MBq/mL 5mCi/mL DATSCAN INJ.SOL 74MBq/mL 10mCi/mL
| DATSCAN INJ.SOL 74MBq/mL 5mCi/mL |
| DATSCAN INJ.SOL 74MBq/mL 10mCi/mL |
CERETEC LY.PD.INJ 500MCG/2xVIAL(KIT) CERETEC LY.PD.INJ 500MCG/5xVIAL(KIT)
| CERETEC LY.PD.INJ 500MCG/2xVIAL(KIT) |
| CERETEC LY.PD.INJ 500MCG/5xVIAL(KIT) |
Partnerships
Latest News
Pharmazac will exhibit at CPHI Milan 2026, held at Fiera Milano from 6 to 8 October. Our stand is 18G25. Three days of conversations await, covering […]
Pharmazac is celebrating 40 years of operation this year. The Health section of the newspaper TO VIMA has published an article featuring Epameinondas Koronis, VP of […]
The Health section of the widespread Greek newspaper TA NEA has published an anniversary feature marking 40 years of Pharmazac, with an opinion piece by Georgios-Damianos […]
Pharmazac SA is heading to euroPLX 90 in Lisbon on 2 and 3 March 2026, a business-only partnering conference for the pharmaceutical and biopharmaceutical industries. Our […]
Unilog has taken over the distribution of Pharmazac products in Greece as of January 2025. The change was made to keep the supply to the market […]
Pharmazac has been named a Diamond Investor at Naftemporiki’s “Diamonds of the Greek Economy 2024 Awards”, a distinction recognising the company’s investment programme. The awards were […]
Pharmazac has a new head office. We are now based at 1, Anastasiou Zaroliagki & 6, Dimitriou Lamprou, Industrial Area GR-19001 Keratea, Greece, placing our head […]
Pharmazac launches the new product Cinacalcet/Pharmazac in 30mg, 60mg and 90mg F.C. Tablets. Cinacalcet indicated for the treatment of secondary Hyperparathyroidism (HPT) in adult patients with […]
We are welcoming KRKA in Greece and we are supporting them as their distributor! Pharmazac is happy to announce that this collaboration will start in December […]
We are becoming a manufacturer and key player in radiopharmaceuticals ! Pharmazac is happy to announce that its radiopharmaceuticals manufacturing unit in the industrial zone of […]
Accreditations
